Drug recall · October 8, 2014
CREON (pancrelipase) Delayed-Release Capsules recall
Why: Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
- Lots / codes
Lot #: 1020156; Expiry: 3/31/2016
- Quantity
- 18,021 Bottles
- Company
- AbbVie Inc, North Chicago, IL
- Distribution
- US: Nationwide
- Initiated
- September 15, 2014 · Voluntary: Firm initiated
- Classified
- September 26, 2014
- Reported
- October 8, 2014
- Ended
- June 22, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Creon
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.